Drug-related problems among community-dwelling elderly with ischemic stroke in China

作者：Lulu Tian, Juan Wu, Zhan Qi, Shijing Qian, Sha Zhang, Danfei Song, Beilei Chen, Deqiu Zhu · 发表于：Advances in Clinical and Experimental Medicine · 年份：2023 · DOI：10.17219/acem/155372 · 被引用次数：8 · 研究领域：Acute Ischemic Stroke Management、Pharmaceutical Practices and Patient Outcomes、Antiplatelet Therapy and Cardiovascular Diseases

BACKGROUND: Ischemic stroke incidence is increasing amongst elderly patients in China; this is closely associated with drug-related problems (DRPs). OBJECTIVES: To evaluate the influencing factors of DRPs among elderly patients with a history of ischemic stroke in the Chinese community and the role clinical pharmacists play in providing solutions. MATERIAL AND METHODS: This study was conducted in 2 community health service centers in Putuo District, Shanghai, China, between December 2018 and June 2019. Demographics and clinical characteristics of the 130 selected patients were collected. Drug-related problems were classified using the Pharmaceutical Care Network Europe (PCNE)-DRP V8.03 classification system. The number, types, causes, interventions, and status of DRPs were then analyzed. RESULTS: The average number of DRPs per patient was 1.3, corresponding to 256 causes. "Treatment effectiveness P1" was identified as the most common problem (75.0%). The main causes were "drug selection C1" (33.2%) and "patient-related C7" (30.9%). Antihypertensive drugs, statins, aspirin, and Chinese patent medicines were the top 4 drugs for DRPs. Age, unintentional medication discrepancy and medication compliance were independent predictors of DRPs. Pharmacists provided 339 interventions, mainly "at drug level I3" (38.9%) and "at patient level I2" (30.7%). Most of the interventions (85.5%) were accepted by the patients and 65.9% of the problems were solved. CONCLUSIONS: The number, types an...